CLINICAL_TRIALS
trial_result
· 2021-11-16
Clinical Trial Update: Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome [Phase 4]
Summary
Phase 4 randomized trial update comparing gabapentin and gabapentin enacarbil for Restless Leg Syndrome; study TERMINATED.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Theresa Zesiewicz, MD | Conditions: Restless Leg Syndrome | Phase 4 | Status: TERMINATED